Related Experiment Video
Updated: May 31, 2026
05:19
A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
Published on: November 7, 2025
Advanced topics in evidence-based urologic oncology: surrogate endpoints
Luke T Lavallée1, Victor M Montori, Stephen E Canfield
1Division of Urology, University of Ottawa, Ottawa, ON, Canada.
Urologic Oncology
|July 6, 2011
Summary
Surrogate endpoints in clinical trials act as substitutes for patient-important outcomes. Validating these markers is crucial for accurate medical decisions and efficient research, especially in urology.
Area of Science:
- Urology
- Clinical Trials
- Biostatistics
Background:
- Clinical trials frequently report data on surrogate endpoints.
- A surrogate endpoint is a measurable marker or sign that stands in for a patient-relevant outcome.
- Proper use of surrogate endpoints can accelerate clinical trials and enhance medical decision-making.
Purpose of the Study:
- To review the concept and application of surrogate endpoints.
- To discuss the criteria for validating surrogate endpoints.
- To examine surrogate endpoints within the specific context of urologic clinical encounters.
Main Methods:
- Literature review of surrogate endpoint methodology.
- Analysis of criteria for surrogate endpoint validation.
- Case study or discussion of surrogate endpoints in urologic trials.
Main Results:
- Surrogate endpoints offer potential benefits for trial efficiency and decision support.
- Strict validation criteria are essential for the reliability of surrogate endpoints.
- The application of surrogate endpoints in urology requires careful consideration of specific disease contexts.
Conclusions:
- Surrogate endpoints are valuable tools in clinical research when rigorously validated.
- Understanding the limitations and validation requirements is key to their appropriate use.
- This review provides a framework for evaluating surrogate endpoints in urologic practice and research.
Related Concept Videos
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:24Kaplan-Meier Approach
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...